DCF — UNIVERSITY OF MINNESOTA MEDICAL CTR
Enterprise Value: $-5.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-5.0B
Enterprise Value
$-1.5B
PV of Cash Flows
$-3.5B
PV of Terminal Value
$-5.6B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.9B | $-334.0M | -18.0% | $-414.4M | $-376.7M |
| Year 2 | $2.0B | $-324.5M | -17.0% | $-407.3M | $-336.6M |
| Year 3 | $2.0B | $-314.1M | -16.0% | $-399.3M | $-300.0M |
| Year 4 | $2.1B | $-313.2M | -15.0% | $-401.0M | $-273.9M |
| Year 5 | $2.1B | $-317.2M | -15.0% | $-407.6M | $-253.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-5.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.8B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18101824010446835
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5